Williams-Sonoma Expects Continued Growth and 4 Stock Analyses Making Rounds
Williams-Sonoma Inc. (NYSE:WSM): Canaccord does not believe investors fully appreciate Williams-Sonoma Inc.’s growth potential of their e-commerce business. The firm anticipates that internet sales growth will continue itheir 14% year-over-year pass and believes that they can protect their positioning with product exclusivity and effective marketing. Shares are Buy rated with a $55 price target.
Amarin Corporation plc (NASDAQ:AMRN): Jefferies said they learned that the United States Patent Office allowed the key ANCHOR 520 patent, which they see as a major positive for Amarin. Jefferies firm also believes that Amarin’s non-dilutive debt financing and decision to hire a salesforce to launch Vascepa during the first quarter should have been expected due to the lack of clarity around Federal Drug Administration exclusivity. Jefferies keeps a Buy rating on their stock with a $28 price target.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Bed Bath & Beyond, Inc. (NASDAQ:BBBY): Ahead of the company’s third quarter results, Jefferies stated that they would be a buyer of Bed Bath & Beyond shares. The firm’s channel checks indicate the company’s sales trends are solid and they have increased confidence in Bed Bath’s ability to post a 3%-4% comp in thei fourth quarter. Jefferies lowered their price target for the stock from $78 to $72, but keeps a Buy rating on the name.
NICE Systems Ltd. (NASDAQ:NICE): After meeting with NICE, Oppenheimer continues to believe the company’s long-term outlook is positive. The firm reiterates a $40 price target and Outperform rating on the stock.
Allot Communications Ltd. (NASDAQ:ALLT): After Allot Communications Ltd.’s stock fell significantly over the last two trading days, Oppenheimer believes that the weakness was triggered by the United Nation’s approval of an international standard for DPI technology. The firm, however, does not see this development as a near-term threat to Allot’s growth outlook and they maintain an Outperform rating on their shares.
Don’t Miss: Apple Just Can’t Get This Monkey Off Its Back.